These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 23790044)
1. Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours? Sen Gupta P; Grozinsky-Glasberg S; Drake WM; Akker SA; Perry L; Grossman AB; Druce MR Clin Endocrinol (Oxf); 2014 Feb; 80(2):246-52. PubMed ID: 23790044 [TBL] [Abstract][Full Text] [Related]
2. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs). Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483 [TBL] [Abstract][Full Text] [Related]
3. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients. van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693 [TBL] [Abstract][Full Text] [Related]
4. [Determination of thresholds values for platelet serotonin and urinary 5-HIAA concentrations for the biological diagnosis of digestive neuroendocrine tumors]. Padelli M; Bruno C; Lemarchand J; Vourc'h P; Andres C; Blasco H; Benz-de Bretagne I Ann Biol Clin (Paris); 2019 Apr; 77(2):161-168. PubMed ID: 30998196 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation. Abeş M; Sarihan H; Madenci E J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110 [TBL] [Abstract][Full Text] [Related]
6. Plasma serotonin precursors and metabolite are correlated with bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Feng Q; Song X; Liu L; Zhou X; Chen Z J Orthop Surg (Hong Kong); 2024; 32(1):10225536231187181. PubMed ID: 38613416 [TBL] [Abstract][Full Text] [Related]
8. Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours. Zandee WT; Kamp K; van Adrichem RC; Feelders RA; de Herder WW Eur J Endocrinol; 2016 Nov; 175(5):361-6. PubMed ID: 27491374 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors. Tirosh A; Nilubol N; Patel D; Kebebew E Endocr Pract; 2018 Aug; 24(8):710-717. PubMed ID: 30084688 [TBL] [Abstract][Full Text] [Related]
10. Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate. Earnshaw SA; Cawte SA; Worley A; Hosking DJ Osteoporos Int; 1998; 8(1):53-60. PubMed ID: 9692078 [TBL] [Abstract][Full Text] [Related]
11. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Laway BA; Goswami R; Singh N; Gupta N; Seith A Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512 [TBL] [Abstract][Full Text] [Related]
12. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors. Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995 [TBL] [Abstract][Full Text] [Related]
13. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis. Patel R; Blake GM; Fogelman I Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990 [TBL] [Abstract][Full Text] [Related]
14. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. Terzi T; Terzi M; Tander B; Cantürk F; Onar M J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660 [TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and vertebral fractures in men. Legrand E; Chappard D; Pascaretti C; Duquenne M; Rondeau C; Simon Y; Rohmer V; Basle MF; Audran M Osteoporos Int; 1999; 10(4):265-70. PubMed ID: 10692973 [TBL] [Abstract][Full Text] [Related]
16. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis. Ribom EL; Ljunggren O; Mallmin H J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191 [TBL] [Abstract][Full Text] [Related]
17. Relationship between bone turnover and bone density at the proximal femur in stroke patients. Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190 [TBL] [Abstract][Full Text] [Related]
18. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169 [TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Haugeberg G; Uhlig T; Falch JA; Halse JI; Kvien TK Arthritis Rheum; 2000 Mar; 43(3):522-30. PubMed ID: 10728744 [TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and fracture threshold in South Indian elderly. Usha G; Krishnaswamy B J Assoc Physicians India; 2002 Feb; 50():247-9. PubMed ID: 12038657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]